Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (19793)	4/29/1998 2:15:00 PM
From: Henry Niman	Respond to of 32384

Looks like the WSJ "Heard on the Street" column was unrelated to the "Heard on the Street" press release: Tuesday April 28, 8:11 pm Eastern Time Company Press Release SOURCE: San Diego Investor Relations Group 'HEARD ON THE STREET: Lions or Lemmings?' San Diego Investor Relations Group Seminar SAN DIEGO, April 28 /PRNewswire/ -- The San Diego Investor Relations Group (SDIRG) announced today the agenda for its annual full-day seminar today, to be held on May 28th at the Sheraton Grand Torrey Pines. Julie Meier Wright of the San Diego Economic Development Corporation will be the keynote speaker. The program will include ''Disclosure Jeopardy,'' a fun, yet educational panel. Alex Muromcew, portfolio manager of the Nicholas Applegate International Core Growth Fund; a panel analysts including high tech, biotech and consumer goods; and a panel of stock-picking experts. David Evans of Bloomberg News Services will be the lunch speaker. Susan Atkins of Ligand Pharmaceuticals, chairs this year's event. ''With the backdrop of this raging bull of a market, we're holding a seminar with experts on international markets, stock picking, disclosure, the regional economy and the future of industries of local importance,'' she said. The San Diego Investor Relations Group is a group of local business professionals involved in investor relations. The annual seminar is a chance for continuing professional development and this year a portion of the proceeds will benefit a scholarship fund for local college students interested in investor relations. The seminar begins at 8 a.m, with a continental breakfast, includes lunch and ends at 4:30 p.m. with a no-host bar benefiting the scholarship fund. The cost is $125 for SDIRG members and $150 for non-members who register before May 11th. After May 11th, the cost is $150 for SDIRG members and $175 for non-members. The cost for students is $30. For further information and to purchase tickets, please call Claudia Jones at (619) 550-7852. SAN DIEGO INVESTOR RELATIONS GROUP CHAIRPERSON Nadine Padilla Biosite Diagnostics (619) 455-4808 (619) 455-4815 (Fax) VICE CHAIRPERSON/ Karen Patchen LOGISTICS ENCAD COMMITTEE (619) 678-5267 (619) 452-6552 (Fax) SECRETARY Annie Kennedy Hendricks IDEC Pharmaceuticals (619) 550-8656 (619) 550-8762 (Fax) TREASURER Peter Wulff Ligand Pharmaceuticals (619) 550-7602 (619) 625-7346 (Fax) SEMINAR/SPECIAL Susan Atkins PROGRAMS Ligand Pharmaceuticals COMMITTEE (619) 550-7687 (619) 625-7346 (Fax) MEMBERSHIP Jane Booth COMMITTEE PR Newswire (619) 456-5740 (6l9) 456-2313 (Fax) COMMUNITY LIAISON Barbara Cook COMMITTEE Tangram Growth Management (619) 546-2907 (619) 546-2812 (Fax) SURVEY Sharon Johnson COMMITTEE Business Wire (619) 686-8650 (619) 686-8659 (Fax) PROGRAMS Kevin Keller COMMITTEE Goss Keller Martinez (619) 792-1919 (619) 792-7010 (Fax) Elizabeth Foster Neurocrine Bioscience, Inc. (619) 658-7757 (619) 658-7605 (Fax) JOB BANK Cheryl Monblatt COMMITTEE Ligand Pharmaceuticals (619) 550-7777 (619) 625-7346 (Fax) SOURCE: San Diego Investor Relations Group